Published by Coherent Market Insights
Posted on September 16, 2021
DNA Sequencing Equipment and Services Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Abbott Laboratories, Agilent Technologies, Bayer Corporation, Beckman Coulter, Commonwealth Biotechnologies, GE Healthcare Life Sciences, Hamilton Thorne Biosciences, Johnson & Johnson, Microchip Biotechnologies, Pacific Biosciences, Siemens AG, Thermo Fisher Scientific Inc., and ZS Genetics.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/355
Next generation sequencing is any of several high-throughput methods to DNA sequencing using the concept of massively parallel processing. DNA sequencing equipment is widely used to determine the precise order of nucleotide within a DNA molecule. The equipment reports the text string in terms of the four bases namely thymine (T), adenine (A), cytosine (C), and guanine (G). DNA sequencing equipment is also capable of analyzing the light signals, which are originated from fluorochromes attached to nucleotides.
Market Dynamics:
Favorable government initiatives to support for large-scale sequencing, advancements in next-generation sequencing (NGS) platforms, and rapid advancements in sequencing technology and bioinformatics are expected to augment the growth of the DNA sequencing equipment and services market. For instance, in 2020, Helix OpCo received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA) for its Helix COVID-19 NGS Test for the detection of the infection.
The outbreak of COVID-19 (SARS-CoV-2) has offered many growth opportunities to market players, as well as many government and non-government organizations. For instance, in June 2020, Illumina received EUA for its COVIDSeq Test that is used to sequence the full genome of the virus. Moreover, in May 2020, Genetics of Mortality in Critical Care, Genomics England, and the National Health Service of U.K. teamed up with Illumina to generate whole-genome sequences of around 35,000 COVID-19 citizens in the U.K.
Furthermore, strategic initiatives undertaken by market players, to expand their presence, are expected to propel the growth of the DNA sequencing equipment and services market. For instance, in 2020, GenapSys raised around US$ 75 million to bring its tabletop DNA sequencer to Asia amid coronavirus outbreak.
Major players in the market are adopting various inorganic strategies, such as merger and collaboration, to strengthen their market position. For instance, in March 20221, RevoluGen, under its collaboration agreement with Tecan, announces the technology validation (by DNA sequencing) of the world’s first automated extraction of library-ready High Molecular Weight (HMW) DNA in a multi-well filter plate format.
In February 2021, SoftBank Group Corp announced to invest US$ 900 million into Pacific Biosciences to strengthen Pacific’s position in the long-read DNA sequencing market.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/355
Reasons to Purchase this Report
• Current and future of global DNA Sequencing Equipment and Services Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post DNA Sequencing Equipment and Services Market Insights Suggesting the Bright Future as Industry is Observing New Entrants with Huge Investments appeared first on Gatorledger.
DNA Sequencing Equipment and Services Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Abbott Laboratories, Agilent Technologies, Bayer Corporation, Beckman Coulter, Commonwealth Biotechnologies, GE Healthcare Life Sciences, Hamilton Thorne Biosciences, Johnson & Johnson, Microchip Biotechnologies, Pacific Biosciences, Siemens AG, Thermo Fisher Scientific Inc., and ZS Genetics.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/355
Next generation sequencing is any of several high-throughput methods to DNA sequencing using the concept of massively parallel processing. DNA sequencing equipment is widely used to determine the precise order of nucleotide within a DNA molecule. The equipment reports the text string in terms of the four bases namely thymine (T), adenine (A), cytosine (C), and guanine (G). DNA sequencing equipment is also capable of analyzing the light signals, which are originated from fluorochromes attached to nucleotides.
Market Dynamics:
Favorable government initiatives to support for large-scale sequencing, advancements in next-generation sequencing (NGS) platforms, and rapid advancements in sequencing technology and bioinformatics are expected to augment the growth of the DNA sequencing equipment and services market. For instance, in 2020, Helix OpCo received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA) for its Helix COVID-19 NGS Test for the detection of the infection.
The outbreak of COVID-19 (SARS-CoV-2) has offered many growth opportunities to market players, as well as many government and non-government organizations. For instance, in June 2020, Illumina received EUA for its COVIDSeq Test that is used to sequence the full genome of the virus. Moreover, in May 2020, Genetics of Mortality in Critical Care, Genomics England, and the National Health Service of U.K. teamed up with Illumina to generate whole-genome sequences of around 35,000 COVID-19 citizens in the U.K.
Furthermore, strategic initiatives undertaken by market players, to expand their presence, are expected to propel the growth of the DNA sequencing equipment and services market. For instance, in 2020, GenapSys raised around US$ 75 million to bring its tabletop DNA sequencer to Asia amid coronavirus outbreak.
Major players in the market are adopting various inorganic strategies, such as merger and collaboration, to strengthen their market position. For instance, in March 20221, RevoluGen, under its collaboration agreement with Tecan, announces the technology validation (by DNA sequencing) of the world’s first automated extraction of library-ready High Molecular Weight (HMW) DNA in a multi-well filter plate format.
In February 2021, SoftBank Group Corp announced to invest US$ 900 million into Pacific Biosciences to strengthen Pacific’s position in the long-read DNA sequencing market.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/355
Reasons to Purchase this Report
• Current and future of global DNA Sequencing Equipment and Services Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post DNA Sequencing Equipment and Services Market Insights Suggesting the Bright Future as Industry is Observing New Entrants with Huge Investments appeared first on Gatorledger.
Explore more articles in the Research Reports category
